$4.10
+0 (+0%)
At Close: Sep 04, 2020
Analysts Conflicted on These Healthcare Names: Progenics (NASDAQ: PGNX) and Cyclerion Therapeutics (NASDAQ: CYCN)
05:39pm, Monday, 16'th Mar 2020
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Progenics (PGNX – Research Report)
Sign In
Buy PGNX